Related Experiment Video
Updated: Jul 19, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stephen J Stray1, Adam Zlotnick
1Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA.
Journal of Molecular Recognition : JMR
|September 29, 2006
Summary
The antiviral compound BAY 41-4109 affects Hepatitis B virus (HBV) capsid assembly, promoting polymer formation and destabilizing capsids at higher concentrations. This suggests a dual mechanism for inhibiting HBV replication.
Area of Science:
- Virology
- Structural Biology
- Antiviral Drug Development
Background:
- Hepatitis B virus (HBV) replication is targeted by antiviral compounds.
- The HBV capsid, an icosahedral structure of 120 protein dimers, is a key target for antiviral strategies.
- Heteroaryldihydropyrimidine (HAP) compounds show promise in inhibiting HBV production.
Purpose of the Study:
- To investigate the effect of the HAP antiviral compound BAY 41-4109 on HBV capsid assembly.
- To determine how BAY 41-4109 interacts with preformed HBV capsids.
Main Methods:
- In vitro studies of HBV capsid assembly in the presence of BAY 41-4109.
- Analysis of the effect of BAY 41-4109 on preformed HBV capsids at various concentrations.
- Comparison of BAY 41-4109's effects with related HAP molecules.
Main Results:
- BAY 41-4109 accelerates and misdirects HBV capsid assembly, forming non-capsid polymers even at low concentrations (1 HAP:5 dimers).
- Unlike HAP-1, BAY 41-4109 did not yield stable assembly intermediates, indicating nucleation-rate-dependent kinetics.
- Preformed capsids were stabilized by BAY 41-4109 up to a 1:2 dimer ratio, but destabilized at higher ratios (1:1 and above), forming large polymers.
- Evidence suggests two distinct drug-binding sites on HBV capsids with differential effects on stability.
Conclusions:
- BAY 41-4109 inhibits HBV by disrupting capsid assembly and stability.
- The compound's dual action, stabilizing at low concentrations and destabilizing at high concentrations, points to distinct binding sites.
- HAP compounds like BAY 41-4109 offer a potential therapeutic strategy by interfering with essential viral structural components.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...